Table of Contents 1 Avian Influenza Vaccines Market Overview 1.1 Product Overview and Scope of Avian Influenza Vaccines 1.2 Avian Influenza Vaccines Segment by Type 1.2.1 Global Avian Influenza Vaccines Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Type H5 1.2.3 Type H9 1.2.4 Other 1.3 Avian Influenza Vaccines Segment by Application 1.3.1 Avian Influenza Vaccines Sales Comparison by Application: 2020 VS 2026 1.3.2 Chicken 1.3.3 Duck & Goose 1.3.4 Other 1.4 Global Avian Influenza Vaccines Market Size Estimates and Forecasts 1.4.1 Global Avian Influenza Vaccines Revenue 2015-2026 1.4.2 Global Avian Influenza Vaccines Sales 2015-2026 1.4.3 Avian Influenza Vaccines Market Size by Region: 2020 Versus 2026 2 Global Avian Influenza Vaccines Market Competition by Manufacturers 2.1 Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2015-2020) 2.2 Global Avian Influenza Vaccines Revenue Share by Manufacturers (2015-2020) 2.3 Global Avian Influenza Vaccines Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Avian Influenza Vaccines Manufacturing Sites, Area Served, Product Type 2.5 Avian Influenza Vaccines Market Competitive Situation and Trends 2.5.1 Avian Influenza Vaccines Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Avian Influenza Vaccines Players (Opinion Leaders) 3 Avian Influenza Vaccines Retrospective Market Scenario by Region 3.1 Global Avian Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Avian Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Avian Influenza Vaccines Market Facts & Figures by Country 3.3.1 North America Avian Influenza Vaccines Sales by Country 3.3.2 North America Avian Influenza Vaccines Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Avian Influenza Vaccines Market Facts & Figures by Country 3.4.1 Europe Avian Influenza Vaccines Sales by Country 3.4.2 Europe Avian Influenza Vaccines Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Avian Influenza Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific Avian Influenza Vaccines Sales by Region 3.5.2 Asia Pacific Avian Influenza Vaccines Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Avian Influenza Vaccines Market Facts & Figures by Country 3.6.1 Latin America Avian Influenza Vaccines Sales by Country 3.6.2 Latin America Avian Influenza Vaccines Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa Avian Influenza Vaccines Sales by Country 3.7.2 Middle East and Africa Avian Influenza Vaccines Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Avian Influenza Vaccines Historic Market Analysis by Type 4.1 Global Avian Influenza Vaccines Sales Market Share by Type (2015-2020) 4.2 Global Avian Influenza Vaccines Revenue Market Share by Type (2015-2020) 4.3 Global Avian Influenza Vaccines Price Market Share by Type (2015-2020) 4.4 Global Avian Influenza Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Avian Influenza Vaccines Historic Market Analysis by Application 5.1 Global Avian Influenza Vaccines Sales Market Share by Application (2015-2020) 5.2 Global Avian Influenza Vaccines Revenue Market Share by Application (2015-2020) 5.3 Global Avian Influenza Vaccines Price by Application (2015-2020) 6 Company Profiles and Key Figures in Avian Influenza Vaccines Business 6.1 Merial 6.1.1 Corporation Information 6.1.2 Merial Description, Business Overview and Total Revenue 6.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Merial Products Offered 6.1.5 Merial Recent Development 6.2 CEVA 6.2.1 CEVA Avian Influenza Vaccines Production Sites and Area Served 6.2.2 CEVA Description, Business Overview and Total Revenue 6.2.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.2.4 CEVA Products Offered 6.2.5 CEVA Recent Development 6.3 Zoetis 6.3.1 Zoetis Avian Influenza Vaccines Production Sites and Area Served 6.3.2 Zoetis Description, Business Overview and Total Revenue 6.3.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Zoetis Products Offered 6.3.5 Zoetis Recent Development 6.4 Elanco (Lohmann ) 6.4.1 Elanco (Lohmann ) Avian Influenza Vaccines Production Sites and Area Served 6.4.2 Elanco (Lohmann ) Description, Business Overview and Total Revenue 6.4.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Elanco (Lohmann ) Products Offered 6.4.5 Elanco (Lohmann ) Recent Development 6.5 Merck Animal Health 6.5.1 Merck Animal Health Avian Influenza Vaccines Production Sites and Area Served 6.5.2 Merck Animal Health Description, Business Overview and Total Revenue 6.5.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Merck Animal Health Products Offered 6.5.5 Merck Animal Health Recent Development 6.6 Avimex Animal Health 6.6.1 Avimex Animal Health Avian Influenza Vaccines Production Sites and Area Served 6.6.2 Avimex Animal Health Description, Business Overview and Total Revenue 6.6.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Avimex Animal Health Products Offered 6.6.5 Avimex Animal Health Recent Development 7 Avian Influenza Vaccines Manufacturing Cost Analysis 7.1 Avian Influenza Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Avian Influenza Vaccines 7.4 Avian Influenza Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Avian Influenza Vaccines Distributors List 8.3 Avian Influenza Vaccines Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Avian Influenza Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Avian Influenza Vaccines by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Avian Influenza Vaccines by Type (2021-2026) 10.2 Avian Influenza Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Avian Influenza Vaccines by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Avian Influenza Vaccines by Application (2021-2026) 10.3 Avian Influenza Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Avian Influenza Vaccines by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Avian Influenza Vaccines by Region (2021-2026) 10.4 North America Avian Influenza Vaccines Estimates and Projections (2021-2026) 10.5 Europe Avian Influenza Vaccines Estimates and Projections (2021-2026) 10.6 Asia Pacific Avian Influenza Vaccines Estimates and Projections (2021-2026) 10.7 Latin America Avian Influenza Vaccines Estimates and Projections (2021-2026) 10.8 Middle East and Africa Avian Influenza Vaccines Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Avian Influenza Vaccines Sales (M Doses) Growth Rate Comparison by Type (2015-2026) Table 2. Global Avian Influenza Vaccines Sales (M Doses) Comparison by Application: 2020 VS 2026 Table 3. Global Avian Influenza Vaccines Market Size by Type (M Doses) (US$ Million) (2020 VS 2026) Table 4. Global Key Avian Influenza Vaccines Manufacturers Covered in This Study Table 5. Global Avian Influenza Vaccines Sales (M Doses) by Manufacturers (2015-2020) Table 6. Global Avian Influenza Vaccines Sales Share by Manufacturers (2015-2020) Table 7. Global Avian Influenza Vaccines Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Avian Influenza Vaccines Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Avian Influenza Vaccines Average Price (USD/K Doses) of Key Manufacturers (2015-2020) Table 10. Manufacturers Avian Influenza Vaccines Sales Sites and Area Served Table 11. Manufacturers Avian Influenza Vaccines Product Types Table 12. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avian Influenza Vaccines as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Avian Influenza Vaccines Players Table 16. Global Avian Influenza Vaccines Sales (M Doses) by Region (2015-2020) Table 17. Global Avian Influenza Vaccines Sales Market Share by Region (2015-2020) Table 18. Global Avian Influenza Vaccines Revenue (Million US$) by Region (2015-2020) Table 19. Global Avian Influenza Vaccines Revenue Market Share by Region (2015-2020) Table 20. North America Avian Influenza Vaccines Sales by Country (2015-2020) (M Doses) Table 21. North America Avian Influenza Vaccines Sales Market Share by Country (2015-2020) Table 22. North America Avian Influenza Vaccines Revenue by Country (2015-2020) (US$ Million) Table 23. North America Avian Influenza Vaccines Revenue Market Share by Country (2015-2020) Table 24. Europe Avian Influenza Vaccines Sales by Country (2015-2020) (M Doses) Table 25. Europe Avian Influenza Vaccines Sales Market Share by Country (2015-2020) Table 26. Europe Avian Influenza Vaccines Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Avian Influenza Vaccines Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Avian Influenza Vaccines Sales by Region (2015-2020) (M Doses) Table 29. Asia Pacific Avian Influenza Vaccines Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Avian Influenza Vaccines Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Avian Influenza Vaccines Revenue Market Share by Region (2015-2020) Table 32. Latin America Avian Influenza Vaccines Sales by Country (2015-2020) (M Doses) Table 33. Latin America Avian Influenza Vaccines Sales Market Share by Country (2015-2020) Table 34. Latin America Avian Influenza Vaccines Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Avian Influenza Vaccines Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Avian Influenza Vaccines Sales by Country (2015-2020) (M Doses) Table 37. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Country (2015-2020) Table 40. Global Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020) Table 41. Global Avian Influenza Vaccines Sales Share by Type (2015-2020) Table 42. Global Avian Influenza Vaccines Revenue (Million US$) by Type (2015-2020) Table 43. Global Avian Influenza Vaccines Revenue Share by Type (2015-2020) Table 44. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2015-2020) Table 45. Global Avian Influenza Vaccines Sales (M Doses) by Application (2015-2020) Table 46. Global Avian Influenza Vaccines Sales Market Share by Application (2015-2020) Table 47. Global Avian Influenza Vaccines Sales Growth Rate by Application (2015-2020) Table 48. Merial Avian Influenza Vaccines Corporation Information Table 49. Merial Description and Business Overview Table 50. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 51. Merial Main Product Table 52. Merial Recent Development Table 53. CEVA Avian Influenza Vaccines Corporation Information Table 54. CEVA Corporation Information Table 55. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 56. CEVA Main Product Table 57. CEVA Recent Development Table 58. Zoetis Avian Influenza Vaccines Corporation Information Table 59. Zoetis Corporation Information Table 60. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 61. Zoetis Main Product Table 62. Zoetis Recent Development Table 63. Elanco (Lohmann ) Avian Influenza Vaccines Corporation Information Table 64. Elanco (Lohmann ) Corporation Information Table 65. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 66. Elanco (Lohmann ) Main Product Table 67. Elanco (Lohmann ) Recent Development Table 68. Merck Animal Health Avian Influenza Vaccines Corporation Information Table 69. Merck Animal Health Corporation Information Table 70. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 71. Merck Animal Health Main Product Table 72. Merck Animal Health Recent Development Table 73. Avimex Animal Health Avian Influenza Vaccines Corporation Information Table 74. Avimex Animal Health Corporation Information Table 75. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 76. Avimex Animal Health Main Product Table 77. Avimex Animal Health Recent Development Table 78. Sales Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Avian Influenza Vaccines Distributors List Table 81. Avian Influenza Vaccines Customers List Table 82. Market Key Trends Table 83. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 84. Key Challenges Table 85. Global Avian Influenza Vaccines Sales (M Doses) Forecast by Type (2021-2026) Table 86. Global Avian Influenza Vaccines Sales Market Share Forecast by Type (2021-2026) Table 87. Global Avian Influenza Vaccines Revenue (Million US$) Forecast by Type (2021-2026) Table 88. Global Avian Influenza Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 89. Global Avian Influenza Vaccines Sales (M Doses) Forecast by Application (2021-2026) Table 90. Global Avian Influenza Vaccines Revenue (Million US$) Forecast by Application (2021-2026) Table 91. Global Avian Influenza Vaccines Sales (M Doses) Forecast by Region (2021-2026) Table 92. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2021-2026) Table 93. Global Avian Influenza Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) Table 94. Global Avian Influenza Vaccines Revenue Market Share Forecast by Region (2021-2026) Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Avian Influenza Vaccines Figure 2. Global Avian Influenza Vaccines Sales Market Share by Type: 2020 VS 2026 Figure 3. Type H5 Product Picture Figure 4. Type H9 Product Picture Figure 5. Other Product Picture Figure 6. Global Avian Influenza Vaccines Consumption Market Share by Application: 2020 VS 2026 Figure 7. Chicken Figure 8. Duck & Goose Figure 9. Other Figure 10. Global Avian Influenza Vaccines Market Size 2015-2026 (US$ Million) Figure 11. Global Avian Influenza Vaccines Sales Capacity (M Doses) (2015-2026) Figure 12. Global Avian Influenza Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Avian Influenza Vaccines Sales Share by Manufacturers in 2020 Figure 14. Global Avian Influenza Vaccines Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Avian Influenza Vaccines Revenue in 2019 Figure 16. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Avian Influenza Vaccines Sales Market Share by Region (2015-2020) Figure 18. Global Avian Influenza Vaccines Sales Market Share by Region in 2019 Figure 19. Global Avian Influenza Vaccines Revenue Market Share by Region (2015-2020) Figure 20. Global Avian Influenza Vaccines Revenue Market Share by Region in 2019 Figure 21. North America Avian Influenza Vaccines Sales Market Share by Country in 2019 Figure 22. North America Avian Influenza Vaccines Revenue Market Share by Country in 2019 Figure 23. U.S. Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 24. U.S. Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 26. Canada Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Avian Influenza Vaccines Sales Market Share by Country in 2019 Figure 28. Europe Avian Influenza Vaccines Revenue Market Share by Country in 2019 Figure 29. Germany Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 30. Germany Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 32. France Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 34. U.K. Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 36. Italy Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 38. Russia Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Avian Influenza Vaccines Sales Market Share by Region in 2019 Figure 40. Asia Pacific Avian Influenza Vaccines Revenue Market Share by Region in 2019 Figure 41. China Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 42. China Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 44. Japan Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 46. South Korea Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 48. India Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 50. Australia Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 52. Taiwan Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 54. Indonesia Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 56. Thailand Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 58. Malaysia Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 60. Philippines Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 62. Vietnam Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Avian Influenza Vaccines Sales Market Share by Country in 2019 Figure 64. Latin America Avian Influenza Vaccines Revenue Market Share by Country in 2019 Figure 65. Mexico Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 66. Mexico Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 68. Brazil Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 70. Argentina Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Country in 2019 Figure 73. Turkey Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 74. Turkey Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 76. Saudi Arabia Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Avian Influenza Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 78. U.A.E Avian Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Avian Influenza Vaccines by Type (2015-2020) Figure 80. Sales Market Share of Avian Influenza Vaccines by Type in 2019 Figure 81. Revenue Share of Avian Influenza Vaccines by Type (2015-2020) Figure 82. Revenue Market Share of Avian Influenza Vaccines by Type in 2019 Figure 83. Global Avian Influenza Vaccines Sales Growth by Type (2015-2020) (M Doses) Figure 84. Global Avian Influenza Vaccines Sales Market Share by Application (2015-2020) Figure 85. Global Avian Influenza Vaccines Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Avian Influenza Vaccines by Application (2015-2020) Figure 87. Global Revenue Share of Avian Influenza Vaccines by Application in 2020 Figure 88. Merial Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. CEVA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Elanco (Lohmann ) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Avimex Animal Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Price Trend of Key Raw Materials Figure 95. Manufacturing Cost Structure of Avian Influenza Vaccines Figure 96. Manufacturing Process Analysis of Avian Influenza Vaccines Figure 97. Avian Influenza Vaccines Industrial Chain Analysis Figure 98. Channels of Distribution Figure 99. Distributors Profiles Figure 100. Porter's Five Forces Analysis Figure 101. North America Avian Influenza Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 102. North America Avian Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Europe Avian Influenza Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 104. Europe Avian Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Latin America Avian Influenza Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 106. Latin America Avian Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Middle East and Africa Avian Influenza Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 108. Middle East and Africa Avian Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Asia Pacific Avian Influenza Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 110. Asia Pacific Avian Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

Merial CEVA Zoetis Elanco (Lohmann ) Merck Animal Health Avimex Animal Health